There is one clinical trial.
Abstract Background: With Covid-19 pandemic, online education, remote and flexible working were introduced. Thus the process of stay-at-home began. Purpose: The aim of the study is to determine level of physical activity of healthy adults in the pandemic process. Methods: This is a descriptive survey study which was applied via internet. The physical activity level was evaluated with International Physical Activity Questionnaire Short Form. Healthy adults aged 18-65 years who live in Turkey were included in the study.
Description: MET-minute score: International Physical Activity Questionnaires-Short Form (IPAQ-SF): In our study, we used IPAQ-SF which was developed for international screening studies with the support of the WHO. The validity and reliability of the Turkish version of the questionnaire were performed by Sağlam et al. (2010). The short form of the questionnaire (7 questions) provides information about walking, moderate and vigorous activities and time spent sitting. Total score calculation of the short form included the sum of frequency (days) and duration (minutes) of walking, moderate and vigorous activities. The energy required for the activities was calculated with the Metabolic Equivalent of Task (MET)-minute score.Measure: physical activity level Time: 3 months
Data processed on January 01, 2021.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.Drug Reports MeSH Reports HPO Reports